1. Home
  2. CMT vs CRBP Comparison

CMT vs CRBP Comparison

Compare CMT & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Core Molding Technologies Inc

CMT

Core Molding Technologies Inc

HOLD

Current Price

$19.69

Market Cap

164.4M

ML Signal

HOLD

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$8.38

Market Cap

134.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMT
CRBP
Founded
1996
2009
Country
United States
United States
Employees
1570
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
164.4M
134.8M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
CMT
CRBP
Price
$19.69
$8.38
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$46.17
AVG Volume (30 Days)
16.7K
145.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
64.31
EPS
0.93
N/A
Revenue
$284,290,000.00
$4,822,272.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6.66
$220.00
P/E Ratio
$19.83
N/A
Revenue Growth
5.49
97.62
52 Week Low
$12.25
$4.64
52 Week High
$22.29
$20.56

Technical Indicators

Market Signals
Indicator
CMT
CRBP
Relative Strength Index (RSI) 53.21 56.25
Support Level $17.81 $8.39
Resistance Level $19.80 $8.43
Average True Range (ATR) 0.77 0.48
MACD -0.04 0.13
Stochastic Oscillator 70.90 79.61

Price Performance

Historical Comparison
CMT
CRBP

About CMT Core Molding Technologies Inc

Core Molding Technologies Inc operates in the engineered materials market as one operating segment as a molder of thermoplastic and thermoset structural products. It produces and sells molded products for varied markets, including medium and heavy-duty trucks, automobiles, power sports, construction and agriculture, building products, and other industrial markets. The processes include compression molding of sheet molding compound (SMC), resin transfer molding (RTM), liquid molding of dicyclopentadiene (DCPD), spray-up and hand-lay-up, direct long-fiber thermoplastics (D-LFT) and structural foam, and structural web injection molding (SIM). It operates operates in Columbus, Ohio; Gaffney, South Carolina; Winona, Minnesota; Matamoros and Escobedo, Mexico; and Cobourg, Ontario, Canada.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: